Evonik to invest $100 million in Lafayette pharmaceutical plant

Evonik announced a $100 million investment to modernize equipment at its Tippecanoe Labs site in Lafayette, Indiana, over the next five years. The project aims to enhance reliability, enable greater automation, and improve efficiency at the facility, which produces active pharmaceutical ingredients.

“The $100 million investment will help secure these jobs, contribute to the local economy, and strengthen the Greater Lafayette community.”insideindianabusiness.com

• 1 source
• insideindianabusiness.comEvonik to invest $100 million in Lafayette plant – Inside INdiana BusinessAlex BrownJul 8, 2026

Summarized from public sources; check the original articles before acting on it.